BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Bank of America
BAC
|
+$254M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$178M |
| 3 |
Kellanova
K
|
+$128M |
| 4 |
Pfizer
PFE
|
+$100M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$99M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$288M |
| 4 |
Procter & Gamble
PG
|
+$261M |
| 5 |
Apple
AAPL
|
+$214M |
Sector Composition
| 1 | Financials | 12.99% |
| 2 | Technology | 10.02% |
| 3 | Communication Services | 8.45% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Healthcare | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Intrepid Potash
IPI
$392M
| $12.7K | ﹤0.01% |
612
-56
| -8% | -$1.16K |
|
2777
Karyopharm Therapeutics
KPTI
$53.8M
| $12.6K | ﹤0.01% |
90
-27
| -23% | -$3.79K |
|
2778
Veracyte
VCYT
$2.42B
| $12.6K | ﹤0.01% |
1,624
+668
| +70% | +$5.17K |
|
2779
Minerva Neurosciences
NERV
$15M
| $12.5K | ﹤0.01% |
133
-32
| -19% | -$3.01K |
|
|
MRT
2780
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $12.5K | ﹤0.01% |
+1,124
| New | +$12.5K |
|
2781
Triumph Financial, Inc.
TFIN
$1.42B
| $12.3K | ﹤0.01% |
471
-581
| -55% | -$15.2K |
|
2782
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.81B
| $12.3K | ﹤0.01% |
428
-7,566
| -95% | -$217K |
|
2783
Shinhan Financial Group
SHG
$23.7B
| $12.3K | ﹤0.01% |
326
-7,180
| -96% | -$270K |
|
|
OSG
2784
DELISTED
Overseas Shipholding Group Inc.
OSG
| $12.2K | ﹤0.01% |
3,186
-407
| -11% | -$1.56K |
|
|
SMMF
2785
DELISTED
Summit Financial Group, Inc.
SMMF
| $12.2K | ﹤0.01% |
443
-33
| -7% | -$909 |
|
2786
Plug Power
PLUG
$1.74B
| $12.1K | ﹤0.01% |
10,117
-2,396
| -19% | -$2.88K |
|
2787
MacroGenics
MGNX
$109M
| $12.1K | ﹤0.01% |
591
-1,617
| -73% | -$33.1K |
|
|
EMKR
2788
DELISTED
Emcore Corp
EMKR
| $12.1K | ﹤0.01% |
139
-11
| -7% | -$956 |
|
|
COTV
2789
DELISTED
Cotiviti Holdings, Inc.
COTV
| $12.1K | ﹤0.01% |
351
-707
| -67% | -$24.3K |
|
2790
Anterix
ATEX
$397M
| $12K | ﹤0.01% |
534
-182
| -25% | -$4.1K |
|
|
TNAV
2791
DELISTED
Telenav Inc.
TNAV
| $12K | ﹤0.01% |
1,708
-484
| -22% | -$3.41K |
|
2792
BankFinancial
BFIN
$154M
| $12K | ﹤0.01% |
812
-306
| -27% | -$4.54K |
|
|
SIGM
2793
DELISTED
Sigma Designs Inc
SIGM
| $12K | ﹤0.01% |
1,999
-660
| -25% | -$3.96K |
|
2794
NovoCure
NVCR
$1.37B
| $11.9K | ﹤0.01% |
1,522
-2,666
| -64% | -$20.9K |
|
2795
Citizens
CIA
$273M
| $11.9K | ﹤0.01% |
1,210
-1,942
| -62% | -$19.1K |
|
|
GLUU
2796
DELISTED
Glu Mobile Inc.
GLUU
| $11.8K | ﹤0.01% |
6,080
-1,429
| -19% | -$2.77K |
|
2797
Potbelly
PBPB
$514M
| $11.8K | ﹤0.01% |
914
-1,088
| -54% | -$14K |
|
|
LUMO
2798
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $11.8K | ﹤0.01% |
127
-118
| -48% | -$10.9K |
|
2799
Novanta
NOVT
$4.14B
| $11.7K | ﹤0.01% |
558
-1,626
| -74% | -$34.1K |
|
|
BBBY
2800
Bed Bath & Beyond, Inc.
BBBY
$607M
| $11.7K | ﹤0.01% |
809
-643
| -44% | -$9.31K |
|